Skip to main content
. Author manuscript; available in PMC: 2014 Nov 16.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007396. doi: 10.1002/14651858.CD007396.pub2
Methods RCT 2-arm parallel group design.
Participants Brazil: hospital.
56 women.
No information in abstract about participant inclusion criteria or characteristics
Interventions Experimental: IM nalbuphine 10 mg.
Control: IM pethidine 100 mg.
Outcomes Analgesia and side effects.
Neonatal: Apgar score.
Notes Abstract only: insufficient information about participants.
Not reported if > 1 dose given or anti-emetic.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection bias) High risk Described as “randomly selected” but not explained how.
Allocation concealment (selection bias) Unclear risk Not mentioned.
Blinding (performance bias and detection bias)
Women
Unclear risk Not mentioned.
Blinding (performance bias and detection bias)
Clinical staff
Unclear risk Not mentioned.
Blinding (performance bias and detection bias)
Outcome assessor
Unclear risk Not mentioned.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not mentioned.
Selective reporting (reporting bias) Unclear risk Impossible to decipher.
Other bias Unclear risk Impossible to decipher.